We measured cytokine secretion patterns in peripheral blood and granulation tissue by flow cytometry in 16 human immunodeficiency virus (HIV) positive and 26 HIV negative patients with spinal tuberculosis. Anti-retroviral therapy was not prescribed. There were no significant differences in the postoperative morbidity and neurological recovery between the two groups.
Introduction
Tuberculous spondylitis, which accounts for up to 60% of all bone and joint tuberculosis (TB) typically affects contiguous vertebral bodies and the intervening disc spaces [7] . Human immunodeficiency virus (HIV) dramatically increases the risk of reactivation of a latent focus of infection and progression of the primary infection to a more atypical and disseminated extrapulmonary manifestation [2, 5, 12] . The development of TB in this group is associated with accelerated rates of decline in the numbers of CD4 lymphocytes [11] . A recent study on spinal TB concluded that good clinical outcomes could be expected irrespective of the HIV status [12] .
The immune response in pulmonary TB has been extensively reported [10, 14, 16, 17] . There has been no study to our knowledge on the immune responses in granulation tissue of spinal TB. We compared the clinical outcome and the cytokine secretion patterns of monocytes and lymphocytes in peripheral blood and granulation tissue in the HIV positive and negative patients who underwent surgery for spinal TB.
Patients and methods
The ethics committee of the medical faculty approved a study to evaluate the immunological response and clinical outcome in patients with spinal TB. The study was conducted between January and December 1998 (Table 1) . Twenty-five patients presented with neurological deficit and 17 had progressive pain and deformity. All patients received preoperative nutritional support and anti-TB treatment. Anterior spinal decompression [trans-thoracic (33) and retroperitoneal (9) ] was performed on all patients. The diseased bodies were excised and the spinal cord decompressed by removing the extradural granulation tissue. The anterior column was supported with an appropriate length of fresh, frozen allograft. Therapeutic antibiotics (first generation cephalosporins) were administered postoperatively for 7 days in all patients. Anti-retroviral therapy was not instituted in the 16 HIV positive patients.
Sample collection and processing
Prior to induction for surgery two tubes with EDTA anticoagulated blood and one tube heparin anticoagulated blood were obtained from each patient. The extradural granulation tissue was harvested and transported immediately to the laboratory on ice. Full blood counts were done in a Coulter STKS (Beckman Coulter, USA) and differential counts were verified manually.
Immunophenotyping of peripheral blood was performed using commercially available monoclonal antibodies conjugated to fluorescein-isothiocyanate (FITC), or phyco-erythrin (PE) fluorescent molecules on a Facs Vantage Flow Cytometer (Becton-Dickinson, USA). The following monoclonal antibodies (Beckman Coulter) were used: anti-CD3, anti-CD4, anti-CD8, anti-CD56, anti-CD19, anti-CD29, anti-CD45RA. Dual marker staining was undertaken to analyze subsets of CD4-positive memory and naive cells and appropriate isotypic control antibodies were used to define negative threshold values. Lymphocytes and monocytes were gated on their forward and side scatter properties and the fidelity of each gate was assessed using CD45/CD14 staining.
Isolation and in vitro stimulation of mononuclear cells from peripheral blood and granulation tissue The heparin anticoagulated blood was diluted 1:1 with 0.1% fetal calf serum (FCS)/RPMI, layered onto Ficoll Hypaque (Histopaque, Sigma Chemicals, St. Louis, MO, USA; specific gravity1.007 g/ml) and centrifuged at 400xg for 40 min at room temperature. The mononuclear cell layer was removed, washed twice with 0.1% FCS/RPMI 1640 (GIBCO-BRL, USA), counted and tested for viability using propidium iodide staining (Sigma) by flow cytometry. 10 6 viable cells per ml complete RPMI (10% FCS, (GIBCO), 10 mmol/l L-glutamine, 10 mmol/l hepes, (GIBCO penicillin/streptomycin 50 U) (Sigma) were cultured for various times (1-12 h) in the presence or absence of 10 ng/ml phorbol-myristate-acetate (PMA) + 1 micromol/l ionomycin (Sigma Chemicals) Brefeldin A 1 mg/ml (Boehringer Mannheim, Germany) was used in cultures to inhibit the secretion of proteins into the culture supernatants, enabling the detection of intracellular cytokines by flow cytometry [13, 15] . The granulation tissue was mechanically teased with a scalpel in RPMI-1640 tissue culture medium. The homogenate was aspirated a few times with an 18-gauge needle, layered on a lymphocyte gradient (Histopaque Sigma) and processed as for peripheral blood.
Intracellular cytokine determination by flow cytometry
Cells from the tissue culture (peripheral blood and granulation tissue) were harvested, fixed in 4% paraformaldehyde, permeabilised in 0.1% Triton X100 in phosphate buffered saline (PBS pH 7.2), (Sigma) and washed in 0.1% FCS/PBS. After an initial blocking step with Fc-Block (purified anti-mouse CD16/CD32), (PharMingen San Diego, Calif., USA) the cells were stained with anti-IL2-FITC, γ-interferon FITC, IL4-PE, IL6-PE (Beckman-Coulter), IL12-PE, IL10-PE, TNFα-FITC (PharMingen). Isotypic controls were used to determine negative responses and double positive cells were stained with combinations of the above antibodies. Anti-vimentin antibodies/FITC labelled (Dako, Copenhagen, Denmark), which stain intra-cellular microtubules were used to determine the permeability action efficiency. The cells were incubated in the dark at room temperature and washed in 0.1% FCS/PBS and analyzed by flow cytometry on a FACS Vantage flow cytometer (Becton Dickinson). Ten thousand events were acquired and analyzed in Cell Quest software (Becton Dickinson)
Statistical analysis
The means and standard deviation were calculated and statistically analyzed using the Mann-Whitney U-Test for unpaired non-parametric data. A P-value of <0.05 was considered to be statistically significant.
Results
Clinical outcome measures in the HIV positive and HIV negative patients
The patients were followed-up for a minimum of 11.5 months (range 8.5-19 months). There were no significant differences in the postoperative complications in both groups (Table 1) . A patient developed recurrent pleural effusion, which resolved with tapping and anti-TB medication and another had superficial wound sepsis, which healed without any sequelae. Death due to ketoacidosis occurred in a non-insulin-dependent diabetic patient at 4 months post-surgery. The neurological recovery improved by two Frankel grades [8] at 6-months' followup in the majority of patients.
Comparison of cytokine secretion patterns between HIV positive and negative patients The HIV positive group had a significantly lower CD4 count (P<0.05, Table 2 ). There were no differences in the cytokine secretion patterns in peripheral blood, except for an increase in IL12 positive monocytes in the HIV negative group (P<0.05, Table 3 ). The mononuclear cells isolated from the granulation tissue did not show a preferential expression pattern for most cytokines measured in the HIV positive and negative patients. However, the expression of IL4 positive lymphocytes was higher in the negative patients (P<0.05, Table 4 ). The cyto- 
Discussion
The recent resurgence of TB worldwide has several underlying causes, but the HIV infection has undoubtedly been a key co-factor in the current TB epidemic [12] . A survey in 1998 revealed 22.8% of the women attending antenatal clinics of the public health facilities in South Africa were infected with HIV [1, 4] . Since TB is endemic, the influence of HIV is of concern, particularly with the emergence of multi-drug-resistant strains. The remarkable susceptibility of patients with AIDS to develop TB has shown the critical role of CD4 lymphocytes in protective immunity [2] . The dually infected individual in most cases is infected with TB before HIV and has 170-fold increased risk of reactivation of TB [5] . In the absence of immunological surveillance by CD4 cells 5-10% of persons with latent foci of TB have the potential to break down and reactivate each year.
In a study on tuberculous osteomyelitis (12 patients) of whom 58% were HIV positive the immunological response was assessed in whole blood by using indirect cytokine proliferation assays [6] . Plasma IL6 levels were significantly elevated in TB as compared to controls. There were no differences in the cytokine levels between bacterial and TB osteomyelitis. The authors used peripheral blood leukocytes in their study and were unable to demonstrate the cell types responsible for cytokine secretion. They recommended measuring cytokines at local areas of infection as opposed to measuring plasma levels since systemic inflammatory markers correlate poorly with clinical and laboratory parameters. The disadvantages of measuring cytokines in plasma either directly or indirectly are that the potential sources of cytokine are unknown and in addition cytokines in plasma are labile with short half-lives. This is the first study to our knowledge describing the cytokine expression patterns of lymphocytes and monocytes in the granulation tissue of patients with spinal tuberculosis who were HIV positive and negative. The rationale for culturing lymphocytes and monocytes from granulation tissue was to increase the potential of these cells to secrete the cytokines marked kine secretion patterns showed that both cell-mediated (IL6, IL12) and humoral immune responses (IL4, IL10) were greater in the granulation tissue when compared to peripheral blood in both HIV-positive and HIV-negative patients with spinal TB.
for their initial commitment response (TB) [15] . Significant increases in IL6 and IL12 in lymphocytes and similar increases in IL4, IL6, IL10, IL12 secreting monocytes in granulation tissue were suggestive of a mixed immune response. The secretion of IL6 is important for the pro-inflammatory process, while IL12 is central for true cell-mediated immunity. IL10 mediates negative control of cell-mediated immunity while enhancing the secretion of cytokines (IL4) involved in antibody formation, which is necessary for the clearance of non-proteinaceous TB antigens [14] . Cytokines, which play an important role in granuloma formation, are increased at the site of pathology, due to increased activity of pro-inflammatory and anti-inflammatory cells, which were responsive to the initial insult [3] . However, the increase in pro-inflammatory cytokines (IL6, IL12) may contribute to extensive tissue destruction mediated through tumor necrosis factor-α (TNF-α), as seen in our HIV positive patients. The increase in both TNF-α and IL6 may potentiate HIV infection by increasing viral replication and load, as demonstrated by other studies [9] . Although TNF-α was elevated in some patients, the increase in IL10 may have exerted negative regulation on its secretion especially in the HIV negative patients. It should be noted that all our patients were on pre-operative anti-TB treatment, and the influence of this on the cytokine expression is unknown.
In a retrospective review of 26 patients with spinal TB (7 HIV positive), Liebert et al. found no differences in the clinical outcome in both groups of patients [12] . They reported significant neurological recovery in 1 HIV positive patient who underwent anterior spinal decompression. The use of anti-retroviral therapy is not mentioned in their study and compared to our group the HIV positive group of patients were older (average age 43 versus 28.5 years). We treat approximately 200 new cases of spinal TB per annum and the protocol includes nutritional support, chemotherapy and surgery. No antiretroviral therapy is available for the HIV positive patients in state hospitals due to economic constraints. Although there were differences in the CD4 counts and cytokine secretion patterns between the two groups, the clinical outcome and complications following surgery were similar despite the lack of anti-retroviral therapy. This may be attributed to adequate pre-operative nutritional support, anti-TB therapy and adequate local cellular immune response.
